Regeneron seems to be one of the most stable constant climbers lately. I know it's expensive right now, but in my opinion, well worth it. Just look at its latest earnings report. Plus, with products like Eylea and Dupixent, I don't think there's a lot to worry about in the future.
There are no replies in this thread yet. Be the first to post a reply below: